Status:
TERMINATED
Observational Study of Rapid Sequence Intubation Drug Delivery Using Intraosseous and Intravenous Access.
Lead Sponsor:
Vidacare Corporation
Conditions:
Airway Control
Eligibility:
All Genders
Brief Summary
This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway di...
Detailed Description
This observational study will evaluate the intubating conditions of patients receiving rapid sequence intubation when receiving paralytic drug delivery via intravenous or intraosseous vascular access ...
Eligibility Criteria
Inclusion
- Requires rapid sequence intubation
- Succinylcholine is chosen paralytic agent
- Intravenous (IV) or Intraosseous (IO) access has been established for rapid sequence intubation
- For IV access patients, their rapid sequence intubation case is the next occurring IV rapid sequence intubation case following an enrolled IO Rapid Sequence Intubation (RSI) case.
Exclusion
- Vascular access other than IV or IO has been established
Key Trial Info
Start Date :
February 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01486407
Start Date
February 1 2012
End Date
December 1 2012
Last Update
January 8 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Christus Spohn Hospital Corpus Christi
Corpus Christi, Texas, United States, 78405
2
Texas Tech University Health Science Center El Paso
El Paso, Texas, United States, 79905